SCOPE of Pain can be used to count toward the DEA licensure 8-hour training requirement as noted in their 3/27/2023 communication as it aligns with SAMHSA's content recommendations opens in a new window required by the 2022 Medication Access and Training Expansion (MATE) Act.
SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Our program consists of:
The FDA has mandated manufacturers of opioid analgesics, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS opens in a new window), to make available comprehensive prescriber education in the safe use of these medications based on the FDA curriculum known as the Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain opens in a new window (PDF). Our curriculum covers all aspects of this blueprint and more to provide a comprehensive educational program.
Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain
Pain is one of the most common conditions addressed in healthcare settings. Over the past two decades increases in opioid prescribing have been associated with increases in opioid-related harms. Effective pain management along with navigating the risks associated with opioid prescribing are essential skills for all health professionals.
Accreditation for individual activities will be found at their landing pages.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf opens in a new window for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
opens in a new window
SCOPE of Pain
© 2026 Trustees of Boston University. Site by Root802 opens in a new window